Targeting H3K9me3 as Novel Therapeutic Strategy in MLLr‐AML

Massett, M. E., Michie, A. M., Vetrie, D. and Huang, X. (2019) Targeting H3K9me3 as Novel Therapeutic Strategy in MLLr‐AML. 59th Annual Scientific Meeting of the British Society for Hematology, Glasgow, UK, 1-3 April 2019.

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Conference or Workshop Item
Additional Information:Abstract published in British Journal of Haematology v. 185(S1):BSH19‐OR‐004
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Huang, Dr Xu
Authors: Massett, M. E., Michie, A. M., Vetrie, D., and Huang, X.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences

University Staff: Request a correction | Enlighten Editors: Update this record